Antibody-mediated neutralization of SARS-CoV-2
Neutralizing antibodies can block infection, clear pathogens, and are essential to provide
long-term immunity. Since the onset of the pandemic, SARS-CoV-2 neutralizing antibodies …
long-term immunity. Since the onset of the pandemic, SARS-CoV-2 neutralizing antibodies …
The success of SARS-CoV-2 vaccines and challenges ahead
K Subbarao - Cell host & microbe, 2021 - cell.com
The rapid and remarkably successful development, manufacture, and deployment of several
effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is now …
effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is now …
Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar
Importance The effect of prior SARS-CoV-2 infection on vaccine protection remains poorly
understood. Objective To assess protection from SARS-CoV-2 breakthrough infection after …
understood. Objective To assess protection from SARS-CoV-2 breakthrough infection after …
Prior infection with SARS-CoV-2 boosts and broadens Ad26. COV2. S immunogenicity in a variant-dependent manner
R Keeton, SI Richardson, T Moyo-Gwete, T Hermanus… - Cell host & …, 2021 - cell.com
Summary The Johnson and Johnson Ad26. COV2. S single-dose vaccine represents an
attractive option for coronavirus disease 2019 (COVID-19) vaccination in countries with …
attractive option for coronavirus disease 2019 (COVID-19) vaccination in countries with …
[HTML][HTML] mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
In addition to serum immunoglobulins, memory B cell (MBC) generation against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is another layer of immune …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is another layer of immune …
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
D Lozano-Ojalvo, C Camara, E Lopez-Granados… - Cell reports, 2021 - cell.com
The rapid development of mRNA-based vaccines against the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) led to the design of accelerated vaccination …
syndrome coronavirus-2 (SARS-CoV-2) led to the design of accelerated vaccination …
Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
N Liebers, C Speer, L Benning… - Blood, The Journal …, 2022 - ashpublications.org
Three reports address the protection of the vulnerable population of patients with
hematologic malignancies in the face of the ongoing COVID pandemic. The reports suggest …
hematologic malignancies in the face of the ongoing COVID pandemic. The reports suggest …
[HTML][HTML] Predictors of nonseroconversion after SARS-CoV-2 infection
W Liu, RM Russell, F Bibollet-Ruche… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection develop SARS-CoV-2–specific antibodies. We show that …
CoV-2) infection develop SARS-CoV-2–specific antibodies. We show that …
[HTML][HTML] Differential immunogenicity of homologous versus heterologous boost in Ad26. COV2. S vaccine recipients
Background Protection offered by coronavirus disease 2019 (COVID-19) vaccines wanes
over time, requiring an evaluation of different boosting strategies to revert such a trend and …
over time, requiring an evaluation of different boosting strategies to revert such a trend and …
High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines
KA Pape, T Dileepan, AJ Kabage, D Kozysa, R Batres… - Cell Reports, 2021 - cell.com
Although both infections and vaccines induce memory B cell (MBC) populations that
participate in secondary immune responses, the MBCs generated in each case can differ …
participate in secondary immune responses, the MBCs generated in each case can differ …